Page last updated: 2024-09-04

pomalidomide and Body Weight

pomalidomide has been researched along with Body Weight in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Brillac, C; Campana, F; El-Cheikh, R; Fau, JB; Koiwai, K; Mace, N; Nguyen, L; Semiond, D	1

Other Studies

1 other study(ies) available for pomalidomide and Body Weight

Article	Year
Drug-Disease Interaction and Time-Dependent Population Pharmacokinetics of Isatuximab in Relapsed/Refractory Multiple Myeloma Patients. CPT: pharmacometrics & systems pharmacology, 2020, Volume: 9, Issue:11 Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; beta 2-Microglobulin; Body Weight; Case-Control Studies; Clinical Trials as Topic; Dexamethasone; Drug Interactions; Female; Histocompatibility Antigens Class I; Humans; Male; Multiple Myeloma; Myeloma Proteins; Neoplasm Recurrence, Local; Pharmaceutical Preparations; Receptors, Fc; Recurrence; Thalidomide; Time Factors	2020

Article

Year

Drug-Disease Interaction and Time-Dependent Population Pharmacokinetics of Isatuximab in Relapsed/Refractory Multiple Myeloma Patients.

CPT: pharmacometrics & systems pharmacology, 2020, Volume: 9, Issue:11

Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; beta 2-Microglobulin; Body Weight; Case-Control Studies; Clinical Trials as Topic; Dexamethasone; Drug Interactions; Female; Histocompatibility Antigens Class I; Humans; Male; Multiple Myeloma; Myeloma Proteins; Neoplasm Recurrence, Local; Pharmaceutical Preparations; Receptors, Fc; Recurrence; Thalidomide; Time Factors

2020